121 related articles for article (PubMed ID: 22901138)
1. Pilot study of the sensitivity and specificity of the DNA integrity assay for stool-based detection of colorectal cancer in Malaysian patients.
Yehya AH; Yusoff NM; Khalid IA; Mahsin H; Razali RA; Azlina F; Mohammed KS; Ali SA
Asian Pac J Cancer Prev; 2012; 13(5):1869-72. PubMed ID: 22901138
[TBL] [Abstract][Full Text] [Related]
2. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.
Abbaszadegan MR; Tavasoli A; Velayati A; Sima HR; Vosooghinia H; Farzadnia M; Asadzedeh H; Gholamin M; Dadkhah E; Aarabi A
World J Gastroenterol; 2007 Mar; 13(10):1528-33. PubMed ID: 17461444
[TBL] [Abstract][Full Text] [Related]
3. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
[TBL] [Abstract][Full Text] [Related]
4. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool.
Calistri D; Rengucci C; Lattuneddu A; Francioni G; Polifemo AM; Nanni O; Saragoni L; Monti F; Ravaioli A; Zoli W; Amadori D
Neoplasia; 2004; 6(5):536-40. PubMed ID: 15548362
[TBL] [Abstract][Full Text] [Related]
5. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
Zou H; Harrington J; Rego RL; Ahlquist DA
Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
7. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
Eguchi S; Kohara N; Komuta K; Kanematsu T
Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
[TBL] [Abstract][Full Text] [Related]
9. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
[TBL] [Abstract][Full Text] [Related]
10. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
11. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
12. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
[TBL] [Abstract][Full Text] [Related]
13. Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
[TBL] [Abstract][Full Text] [Related]
14. DNA integrity as a potential marker for stool-based detection of colorectal cancer.
Boynton KA; Summerhayes IC; Ahlquist DA; Shuber AP
Clin Chem; 2003 Jul; 49(7):1058-65. PubMed ID: 12816901
[TBL] [Abstract][Full Text] [Related]
15. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
[TBL] [Abstract][Full Text] [Related]
16. Improved fecal DNA test for colorectal cancer screening.
Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
[TBL] [Abstract][Full Text] [Related]
17. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
18. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
19. Summaries for patients. Stool DNA and occult blood testing to screen for colorectal neoplasia.
Ann Intern Med; 2008 Oct; 149(7):I20. PubMed ID: 18838720
[No Abstract] [Full Text] [Related]
20. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ
Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
